)
)
Kuros Biosciences Investor Relations Material
Latest events
H1 2024
Kuros Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Kuros Biosciences AG
Access all reports
Kuros Biosciences AG, operating under the ticker KURN, is a biotechnology company dedicated to discovering, developing, and delivering innovative fusion technologies for bone grafting. Founded as a spin-off from the Swiss Federal Institute of Technology in Zurich in 2000, Kuros Biosciences has established a significant presence in the field of tissue repair and regeneration. The company's flagship product line, MagnetOs, is designed for applications in spinal fusion, trauma, fracture repair, and as surgical sealants. The company is headquartered in Zurich, Switzerland, and its shares are listed on SIX.
Key slides for Kuros Biosciences AG
H1 2024
Kuros Biosciences AG
H1 2024
Kuros Biosciences AG
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
KURN
Country
🇨🇭 Switzerland